TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ADUS

Addus HomeCare Corporation

Healthcare · Medical Care Facilities

113.00$ +1.5% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ADUS
Line item 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +32.1% -293.8% – +49.0% -3.4% +77.8% -74.3% -41.6% -118.1% – -37.1% -63.8% +810.3% -63.9% +166.2% +6.8% +3.7% -4.2%
– +1.0% -19.4% -17.6% -12.2% -28.4% -15.1% +77.3% +23.2% +40.9% +0.2% +29.7% +22.4% +14.0% +20.3% -3.0% +0.5% -4.2% +21.3%
– -71.2% +9.2% -14.1% +29.8% +3.0% +51.0% +60.6% +90.2% -31.8% +138.1% +61.0% +40.3% +4.1% +57.1% +12.6% -2.9% +8.2% +47.1%
– – – – – -77.7% -297.9% – +14.6% +43.9% +4.5% -65.1% +43.0% -30.1% +401.2% -7.3% – – –
– – – – – – +795.2% -216.1% – – – -78.2% +1,237.8% +3.6% -164.4% – -24.8% -92.8% -2,622.0%
– -48.4% +65.3% -8.8% -10.0% +102.2% -20.4% +500.2% -55.7% -27.4% +111.2% +47.9% -13.6% +47.8% -32.0% +78.7% +13.9% -36.0% +27.6%
– -55.3% +169.8% -57.6% -83.0% -41.1% – -574.7% -21.3% +102.7% +11.6% +179.3% +178.4% +13.5% -80.4% +153.7% +11.9% +197.4% -90.8%
– – – -88.5% +49.4% +62.8% -100.0% – – – – – – – – – – – –
– – – -187.7% -100.0% – – – +42.5% +888.9% -61.6% +6,602.2% +126.9% -97.8% -71.9% – – – –
– – – – – +10.1% +9.2% – -165.7% – +63.7% +114.2% -45.6% +216.3% -67.9% -307.5% -90.6% – -202.1%
– -20.3% +163.4% -123.1% +225.6% +10.1% +9.2% – -180.9% – -34.7% +197.2% +325.4% -36.6% -80.9% -432.0% -90.6% – -135.4%
– +33,744.4% -191.8% – +304.0% -123.5% – -115.9% – – +1,070.1% -63.6% +148.1% -19.2% -28.6% -473.4% – – -150.7%
– +55.6% -328.5% – +52.6% -7.2% +85.5% -93.6% +2.5% -240.5% – -43.3% -73.4% +1,286.6% -66.0% +177.8% +6.2% +7.4% -6.0%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?